• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因在胎盘成纤维细胞中表达。

The CTLA-4 gene is expressed in placental fibroblasts.

作者信息

Kaufman K A, Bowen J A, Tsai A F, Bluestone J A, Hunt J S, Ober C

机构信息

Department of Human Genetics, The University of Chicago, IL 60637, USA.

出版信息

Mol Hum Reprod. 1999 Jan;5(1):84-7. doi: 10.1093/molehr/5.1.84.

DOI:10.1093/molehr/5.1.84
PMID:10050667
Abstract

In order to elucidate the mechanisms that ensure survival of the allogeneic fetus, we are investigating the expression pattern of genes that are involved in peripheral self-tolerance in tissues at the maternal-fetal interface. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a negative regulator of T cell activation and may modulate peripheral self-tolerance. Previously, we reported the preferential transmission of maternally-inherited shorter alleles at a 3'-UTR microsatellite locus to liveborn children, but random transmission of paternally-inherited alleles, suggesting that CTLA-4 may be involved in the maintenance of tolerance at the maternal-fetal interface. In this report, we demonstrate that CTLA-4 mRNA and protein are indeed expressed in fetal tissues at the maternal-fetal interface throughout gestation.

摘要

为了阐明确保同种异体胎儿存活的机制,我们正在研究参与母胎界面组织外周自身耐受的基因的表达模式。细胞毒性T淋巴细胞相关蛋白4(CTLA-4)是T细胞活化的负调节因子,可能调节外周自身耐受。此前,我们报道了在一个3'-UTR微卫星位点上,母系遗传的较短等位基因优先传递给活产婴儿,而父系遗传的等位基因则随机传递,这表明CTLA-4可能参与维持母胎界面的耐受性。在本报告中,我们证明CTLA-4 mRNA和蛋白在整个妊娠期母胎界面的胎儿组织中均有表达。

相似文献

1
The CTLA-4 gene is expressed in placental fibroblasts.细胞毒性T淋巴细胞相关抗原4(CTLA-4)基因在胎盘成纤维细胞中表达。
Mol Hum Reprod. 1999 Jan;5(1):84-7. doi: 10.1093/molehr/5.1.84.
2
Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage.母系遗传的CTLA-4微卫星等位基因在特发性复发性流产中的传递不平衡。
J Reprod Immunol. 1998 Nov;40(2):147-57. doi: 10.1016/s0165-0378(98)00073-4.
3
Non-HLA genes and the susceptibility to insulin dependent diabetes: the role of the CTLA-4 gene.非HLA基因与胰岛素依赖型糖尿病易感性:CTLA-4基因的作用
Acta Diabetol. 1996 Dec;33(4):250-2. doi: 10.1007/BF00571558.
4
CTLA-4 and autoimmune thyroid disease: lack of influence of the A49G signal peptide polymorphism on functional recombinant human CTLA-4.细胞毒性T淋巴细胞相关抗原4与自身免疫性甲状腺疾病:A49G信号肽多态性对重组人细胞毒性T淋巴细胞相关抗原4功能无影响
Cell Immunol. 2002 Feb;215(2):133-40. doi: 10.1016/s0008-8749(02)00018-7.
5
Effect of adenovirus-mediated gene transfer with CTLA4-Ig gene in organ transplantation.
Transplant Proc. 1999 Aug;31(5):1944-5. doi: 10.1016/s0041-1345(99)00220-1.
6
The study of CTLA-4 and vitamin D receptor polymorphisms in the Romanian type 1 diabetes population.罗马尼亚1型糖尿病患者群体中CTLA-4和维生素D受体基因多态性的研究。
J Cell Mol Med. 2002 Jan-Mar;6(1):75-81. doi: 10.1111/j.1582-4934.2002.tb00312.x.
7
No evidence to support CTLA-4 as a susceptibility gene in MS families: the Canadian Collaborative Study.无证据支持CTLA-4作为多发性硬化症家族的易感基因:加拿大合作研究。
J Neuroimmunol. 2002 Feb;123(1-2):193-8. doi: 10.1016/s0165-5728(01)00493-3.
8
Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus.系统性红斑狼疮患者的细胞毒性T淋巴细胞抗原4(CTLA-4)二态性
Clin Exp Rheumatol. 1999 Nov-Dec;17(6):725-9.
9
The role of deletion versus regulation in the maintenance of self-tolerance.缺失与调控在维持自身耐受中的作用。
Diabetes Metab Rev. 1997 Dec;13(4):309-14. doi: 10.1002/(sici)1099-0895(199712)13:4<309::aid-dmr199>3.0.co;2-h.
10
Adenoviral vector persistence in vivo with a soluble form of CTLA4.携带可溶性形式细胞毒性T淋巴细胞相关抗原4的腺病毒载体在体内的持久性。
Hum Gene Ther. 1998 Aug 10;9(12):1699-700. doi: 10.1089/hum.1998.9.12-1699.

引用本文的文献

1
Negative Immune Checkpoint Inhibitors.阴性免疫检查点抑制剂
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
2
Immune checkpoint for pregnancy.妊娠的免疫检查点。
Semin Immunopathol. 2025 May 2;47(1):26. doi: 10.1007/s00281-025-01051-y.
3
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy.抗 CTLA-4 纳米抗体作为癌症免疫治疗的一种有前途的方法。
Cell Death Dis. 2024 Jan 8;15(1):17. doi: 10.1038/s41419-023-06391-x.
4
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas.细胞毒性 T 淋巴细胞相关蛋白 4(CTLA4)在催乳素和生长激素分泌性垂体腺瘤的亚群中过表达。
Endocr Relat Cancer. 2023 Nov 22;31(1). doi: 10.1530/ERC-23-0196. Print 2024 Jan 1.
5
Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases.检查点免疫疗法的免疫相关不良反应及其对癌症和自身免疫性疾病患者治疗的影响。
Front Immunol. 2023 Jun 5;14:1197364. doi: 10.3389/fimmu.2023.1197364. eCollection 2023.
6
Association of cytotoxic T-lymphocyte-associated protein 4 polymorphisms with recurrent pregnancy loss: A case-control study.细胞毒性T淋巴细胞相关蛋白4基因多态性与复发性流产的关联:一项病例对照研究。
Int J Reprod Biomed. 2023 Feb 8;21(1):33-43. doi: 10.18502/ijrm.v21i1.12664. eCollection 2023 Jan.
7
Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1.遗传性免疫缺陷及其拟表型:CTLA4与PD-1
Front Immunol. 2022 Jan 28;12:806043. doi: 10.3389/fimmu.2021.806043. eCollection 2021.
8
Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review.检查点抑制剂、生育力、妊娠和性生活:系统评价。
ESMO Open. 2021 Oct;6(5):100276. doi: 10.1016/j.esmoop.2021.100276. Epub 2021 Sep 28.
9
Immune checkpoint inhibitor administration during pregnancy: a case series.孕期免疫检查点抑制剂治疗:病例系列研究。
ESMO Open. 2021 Oct;6(5):100262. doi: 10.1016/j.esmoop.2021.100262. Epub 2021 Sep 3.
10
Beyond T-Cells: Functional Characterization of CTLA-4 Expression in Immune and Non-Immune Cell Types.超越T细胞:免疫和非免疫细胞类型中CTLA-4表达的功能特征
Front Immunol. 2020 Dec 15;11:608024. doi: 10.3389/fimmu.2020.608024. eCollection 2020.